Immersion Corp is a licensing company focused on the acceleration, and scaling, through licensing, of haptic technologies that allow people to use sense of touch to engage with products and experience the digital world around them... Show more
a developer of patented haptic innovations and software
Industry PackagedSoftware
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BAI | 47.54 | 0.45 | +0.96% |
| iShares A.I. Innovation and Tech Active ETF | |||
| OUSM | 46.75 | 0.37 | +0.80% |
| ALPS O'Shares US Small-Cap Quality Dividend ETF (OUSM) | |||
| DBP | 99.25 | 0.55 | +0.55% |
| Invesco DB Precious Metals Fund (DBP) | |||
| XYLG | 29.72 | 0.09 | +0.29% |
| Global X S&P 500 Covered Call & Growth ETF (XYLG) | |||
| DDTA | 21.00 | 0.06 | +0.28% |
| Innovator Equity Dual Directional 10 Buffer ETF - April (DDTA) | |||
A.I.dvisor indicates that over the last year, IMMR has been loosely correlated with PATH. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMR jumps, then PATH could also see price increases.
| Ticker / NAME | Correlation To IMMR | 1D Price Change % | ||
|---|---|---|---|---|
| IMMR | 100% | -0.14% | ||
| PATH - IMMR | 46% Loosely correlated | -1.11% | ||
| CPAY - IMMR | 45% Loosely correlated | -0.55% | ||
| DOCN - IMMR | 44% Loosely correlated | -1.29% | ||
| AI - IMMR | 44% Loosely correlated | -1.02% | ||
| NTCT - IMMR | 44% Loosely correlated | +0.48% | ||
More | ||||
| Ticker / NAME | Correlation To IMMR | 1D Price Change % |
|---|---|---|
| IMMR | 100% | -0.14% |
| Packaged Software industry (225 stocks) | 36% Loosely correlated | -0.45% |
| Technology Services industry (399 stocks) | 15% Poorly correlated | -0.57% |
On September 17, 2026, the Stochastic Oscillator for IMMR moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 64 instances where the indicator left the oversold zone. In 45 of the 64 cases the stock moved higher in the following days. This puts the odds of a move higher at over 70%.
Following a +3.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMMR advanced for three days, in 196 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
IMMR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on September 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IMMR as a result. In 72 of 107 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 67%.
IMMR moved below its 50-day moving average on September 24, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for IMMR crossed bearishly below the 50-day moving average on September 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
The Aroon Indicator for IMMR entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.809) is normal, around the industry mean (51.871). P/E Ratio (21.412) is within average values for comparable stocks, (83.426). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (3.145). Dividend Yield (0.037) settles around the average of (0.011) among similar stocks. P/S Ratio (0.137) is also within normal values, averaging (70.180).
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. IMMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 93 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMMR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.